Bridging the Gap: Manufacturing Software and the Paperless Imperative.

You know you need to go paperless on your manufacturing floor, to reduce human error, increase time to market and get quality off your back. But what's the best solution? It depends on your needs.

Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America.

Moderna, Inc announced a distribution service agreement with Adium Pharma S.A., a leading private Latin American pharmaceutical company, to support the commercialization of the Moderna COVID-19 vaccine, Spikevax across Latin America.

To Enhance Biologics Dual Acquisition Done By Recipharm.

Recipharm, the Swedish CDMO, which happens to be Moderna's COVID-19 vaccine production partner, has undergone not one but two acquisitions in the week ending February 19th. This expansion is a part of a strategy that Recipharm has been eyeing since last .

Xanadu Licences Intranasal Vaccine Booster To Stop Virus.

Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position itself to give its expertise in the COVID-19 booster vaccines that may prove to be more efficient in stopping the viral infection...

Qatar Airways Cargo welcomes Envirotainer's newest innovation: the Releye RAP.

Qatar Airways Cargo approves Envirotainer's latest innovation – The Releye RAP container. Officially launched on 9 February 2022, and able to accommodate 5 pallets, the Releye RAP is the largest and most technically advanced product in Envirotainer's new generation container series.

PeliBioThermal Opens First Network Station in China.

PeliBioThermal, the life science industry's cold chain partner from discovery to distribution, announces the opening of its first network station in China. Located in Shanghai, the new network station will serve worldwide customers of the Credo on Demand...

Honeywell Teams With AstraZeneca To Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant.

Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential propellants to treat asthma and chronic obstructive pulmonary disease...